Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1

Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1

Introduction/Aim: Immunotherapy with immune checkpoint inhibitors (ICIs) has positively changed the history of several malignant tumors. In parallel, new challenges have emerged in the evaluation of treatment response as a result of their peculiar anticancer effect. In the current study, we aimed to...

Full description

Bibliographic Details
Main Authors: Angelo Castello, Sabrina Rossi, Luca Toschi, Egesta Lopci
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
checkpoint inhibitors
18F-FDG PET/CT
RECIST
EORTC
PERCIST
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01090/full

Similar Items

Similar Items